This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 00:21, 13 August 2011 (Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per Chem/Drugbox validation). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 00:21, 13 August 2011 by CheMoBot (talk | contribs) (Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per Chem/Drugbox validation)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) "Zubrin" redirects here. For the aerospace engineer, see Robert Zubrin. Pharmaceutical compound | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATCvet code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
IUPAC name
| |
| PubChem CID | |
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.166.553  |
| Chemical and physical data | |
| Formula | C20H20ClN3O3 |
| Molar mass | 385.844 g/mol g·mol |
| (verify) | |
Tepoxalin is a nonsteroidal anti-inflammatory drug approved for veterinary use (in dogs) in the United States and the European Union. It is primarily used to reduce inflammation and relief of pain caused by musculoskeletal disorders such as hip dysplasia and arthritis.
It is generally marketed under the brand name Zubrin.
References
 | This veterinary medicine–related article is a stub. You can help Misplaced Pages by expanding it. |